| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | arachidonate 12(S)-lipoxygenase activity | 1.31e-07 | 4 | 65 | 3 | GO:0004052 | |
| GeneOntologyMolecularFunction | hepoxilin-epoxide hydrolase activity | 1.04e-05 | 2 | 65 | 2 | GO:0047977 | |
| GeneOntologyMolecularFunction | glucan 1,4-alpha-glucosidase activity | 1.04e-05 | 2 | 65 | 2 | GO:0004339 | |
| GeneOntologyMolecularFunction | linoleate 13S-lipoxygenase activity | 3.12e-05 | 3 | 65 | 2 | GO:0016165 | |
| GeneOntologyMolecularFunction | arachidonate 15-lipoxygenase activity | 3.12e-05 | 3 | 65 | 2 | GO:0050473 | |
| GeneOntologyMolecularFunction | carbohydrate binding | 6.54e-05 | 310 | 65 | 7 | GO:0030246 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen | 7.19e-05 | 25 | 65 | 3 | GO:0016702 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen | 8.11e-05 | 26 | 65 | 3 | GO:0016701 | |
| GeneOntologyMolecularFunction | alpha-1,4-glucosidase activity | 1.04e-04 | 5 | 65 | 2 | GO:0004558 | |
| GeneOntologyMolecularFunction | iron ion binding | 2.06e-04 | 166 | 65 | 5 | GO:0005506 | |
| GeneOntologyMolecularFunction | alpha-glucosidase activity | 2.17e-04 | 7 | 65 | 2 | GO:0090599 | |
| GeneOntologyMolecularFunction | dioxygenase activity | 2.94e-04 | 98 | 65 | 4 | GO:0051213 | |
| GeneOntologyMolecularFunction | epoxide hydrolase activity | 5.63e-04 | 11 | 65 | 2 | GO:0004301 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on ether bonds | 7.95e-04 | 13 | 65 | 2 | GO:0016801 | |
| GeneOntologyMolecularFunction | ether hydrolase activity | 7.95e-04 | 13 | 65 | 2 | GO:0016803 | |
| GeneOntologyMolecularFunction | glucosidase activity | 1.07e-03 | 15 | 65 | 2 | GO:0015926 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on glycosyl bonds | 1.25e-03 | 144 | 65 | 4 | GO:0016798 | |
| GeneOntologyMolecularFunction | mechanosensitive monoatomic ion channel activity | 1.54e-03 | 18 | 65 | 2 | GO:0008381 | |
| GeneOntologyMolecularFunction | glucosyltransferase activity | 2.31e-03 | 22 | 65 | 2 | GO:0046527 | |
| GeneOntologyMolecularFunction | oxidoreductase activity | 3.31e-03 | 766 | 65 | 8 | GO:0016491 | |
| GeneOntologyBiologicalProcess | lipoxin biosynthetic process | 1.31e-07 | 4 | 67 | 3 | GO:2001301 | |
| GeneOntologyBiologicalProcess | lipoxin metabolic process | 3.26e-07 | 5 | 67 | 3 | GO:2001300 | |
| GeneOntologyBiologicalProcess | lipoxygenase pathway | 5.31e-06 | 11 | 67 | 3 | GO:0019372 | |
| GeneOntologyBiologicalProcess | leukotriene A4 metabolic process | 1.04e-05 | 2 | 67 | 2 | GO:1901751 | |
| GeneOntologyBiologicalProcess | lipoxin A4 biosynthetic process | 3.11e-05 | 3 | 67 | 2 | GO:2001303 | |
| GeneOntologyBiologicalProcess | detection of mechanical stimulus involved in sensory perception of sound | 5.54e-05 | 23 | 67 | 3 | GO:0050910 | |
| GeneOntologyBiologicalProcess | lipoxin A4 metabolic process | 6.21e-05 | 4 | 67 | 2 | GO:2001302 | |
| GeneOntologyBiologicalProcess | epoxide metabolic process | 1.03e-04 | 5 | 67 | 2 | GO:0097176 | |
| GeneOntologyBiologicalProcess | detection of mechanical stimulus | 1.04e-04 | 75 | 67 | 4 | GO:0050982 | |
| GeneOntologyBiologicalProcess | long-chain fatty acid biosynthetic process | 1.13e-04 | 29 | 67 | 3 | GO:0042759 | |
| GeneOntologyBiologicalProcess | hepoxilin metabolic process | 2.87e-04 | 8 | 67 | 2 | GO:0051121 | |
| GeneOntologyBiologicalProcess | hepoxilin biosynthetic process | 2.87e-04 | 8 | 67 | 2 | GO:0051122 | |
| GeneOntologyBiologicalProcess | response to amphetamine | 2.97e-04 | 40 | 67 | 3 | GO:0001975 | |
| GeneOntologyBiologicalProcess | negative regulation of phosphorylation | 3.18e-04 | 401 | 67 | 7 | GO:0042326 | |
| GeneOntologyBiologicalProcess | response to endoplasmic reticulum stress | 3.91e-04 | 295 | 67 | 6 | GO:0034976 | |
| GeneOntologyCellularComponent | stereocilium tip | 4.85e-05 | 22 | 68 | 3 | GO:0032426 | |
| MousePheno | abnormal cochlear hair cell physiology | 2.33e-05 | 40 | 59 | 4 | MP:0004432 | |
| MousePheno | absent Z line | 5.24e-05 | 3 | 59 | 2 | MP:0004092 | |
| MousePheno | abnormal hair cell physiology | 5.26e-05 | 49 | 59 | 4 | MP:0003879 | |
| Domain | LH2 | 4.46e-07 | 18 | 67 | 4 | SM00308 | |
| Domain | PLAT | 8.64e-07 | 21 | 67 | 4 | PS50095 | |
| Domain | - | 8.64e-07 | 21 | 67 | 4 | 2.60.60.20 | |
| Domain | PLAT | 8.64e-07 | 21 | 67 | 4 | PF01477 | |
| Domain | PLAT/LH2_dom | 8.64e-07 | 21 | 67 | 4 | IPR001024 | |
| Domain | LipOase_mml | 8.76e-07 | 6 | 67 | 3 | IPR001885 | |
| Domain | LIPOXYGENASE_1 | 8.76e-07 | 6 | 67 | 3 | PS00711 | |
| Domain | LipOase_C | 8.76e-07 | 6 | 67 | 3 | IPR013819 | |
| Domain | Lipoxygenase | 8.76e-07 | 6 | 67 | 3 | PF00305 | |
| Domain | LIPOXYGENASE_3 | 8.76e-07 | 6 | 67 | 3 | PS51393 | |
| Domain | LIPOXYGENASE_2 | 8.76e-07 | 6 | 67 | 3 | PS00081 | |
| Domain | LipOase | 8.76e-07 | 6 | 67 | 3 | IPR000907 | |
| Domain | LipOase_Fe_BS | 8.76e-07 | 6 | 67 | 3 | IPR020833 | |
| Domain | LipOase_CS | 8.76e-07 | 6 | 67 | 3 | IPR020834 | |
| Domain | - | 7.13e-06 | 11 | 67 | 3 | 4.10.110.10 | |
| Domain | P_trefoil_dom | 9.49e-06 | 12 | 67 | 3 | IPR000519 | |
| Domain | GGL | 2.39e-05 | 16 | 67 | 3 | SM00224 | |
| Domain | G-gamma | 2.39e-05 | 16 | 67 | 3 | PF00631 | |
| Domain | - | 2.39e-05 | 16 | 67 | 3 | 4.10.260.10 | |
| Domain | Gprotein-gamma | 2.39e-05 | 16 | 67 | 3 | IPR001770 | |
| Domain | G_PROTEIN_GAMMA | 2.39e-05 | 16 | 67 | 3 | PS50058 | |
| Domain | G-protein_gamma-like_dom | 2.39e-05 | 16 | 67 | 3 | IPR015898 | |
| Domain | - | 6.47e-05 | 22 | 67 | 3 | 1.10.196.10 | |
| Domain | DEP | 6.47e-05 | 22 | 67 | 3 | PF00610 | |
| Domain | DEP | 6.47e-05 | 22 | 67 | 3 | PS50186 | |
| Domain | RGS_subdom1 | 6.47e-05 | 22 | 67 | 3 | IPR024066 | |
| Domain | DEP | 6.47e-05 | 22 | 67 | 3 | SM00049 | |
| Domain | DEP_dom | 7.42e-05 | 23 | 67 | 3 | IPR000591 | |
| Domain | NtCtMGAM_N | 7.57e-05 | 4 | 67 | 2 | PF16863 | |
| Domain | Gal_mutarotase_N | 7.57e-05 | 4 | 67 | 2 | IPR031727 | |
| Domain | Glyco_hydro_31_AS | 1.88e-04 | 6 | 67 | 2 | IPR030458 | |
| Domain | Glyco_hydro_31 | 2.63e-04 | 7 | 67 | 2 | IPR000322 | |
| Domain | Glyco_hydro_31 | 2.63e-04 | 7 | 67 | 2 | PF01055 | |
| Domain | GLYCOSYL_HYDROL_F31_1 | 2.63e-04 | 7 | 67 | 2 | PS00129 | |
| Domain | RGS | 2.66e-04 | 35 | 67 | 3 | PF00615 | |
| Domain | RGS | 2.66e-04 | 35 | 67 | 3 | SM00315 | |
| Domain | RGS | 2.89e-04 | 36 | 67 | 3 | PS50132 | |
| Domain | Trefoil | 3.50e-04 | 8 | 67 | 2 | PF00088 | |
| Domain | TMC | 3.50e-04 | 8 | 67 | 2 | PF07810 | |
| Domain | TMC | 3.50e-04 | 8 | 67 | 2 | IPR012496 | |
| Domain | RGS | 3.68e-04 | 39 | 67 | 3 | IPR016137 | |
| Domain | P_TREFOIL_2 | 4.49e-04 | 9 | 67 | 2 | PS51448 | |
| Domain | PD | 4.49e-04 | 9 | 67 | 2 | SM00018 | |
| Domain | CUB | 7.22e-04 | 49 | 67 | 3 | PF00431 | |
| Domain | CUB | 7.67e-04 | 50 | 67 | 3 | SM00042 | |
| Domain | TIL | 8.18e-04 | 12 | 67 | 2 | PF01826 | |
| Domain | C8 | 8.18e-04 | 12 | 67 | 2 | PF08742 | |
| Domain | - | 8.60e-04 | 52 | 67 | 3 | 2.60.120.290 | |
| Domain | Sushi | 8.60e-04 | 52 | 67 | 3 | PF00084 | |
| Domain | CUB | 9.09e-04 | 53 | 67 | 3 | PS01180 | |
| Domain | Glycoside_hydrolase_SF | 9.09e-04 | 53 | 67 | 3 | IPR017853 | |
| Domain | CCP | 9.60e-04 | 54 | 67 | 3 | SM00032 | |
| Domain | Unchr_dom_Cys-rich | 9.64e-04 | 13 | 67 | 2 | IPR014853 | |
| Domain | C8 | 9.64e-04 | 13 | 67 | 2 | SM00832 | |
| Domain | SUSHI | 1.07e-03 | 56 | 67 | 3 | PS50923 | |
| Domain | - | 1.11e-03 | 218 | 67 | 5 | 1.10.10.10 | |
| Domain | TIL_dom | 1.12e-03 | 14 | 67 | 2 | IPR002919 | |
| Domain | Sushi_SCR_CCP_dom | 1.12e-03 | 57 | 67 | 3 | IPR000436 | |
| Domain | CUB_dom | 1.12e-03 | 57 | 67 | 3 | IPR000859 | |
| Domain | VWD | 1.47e-03 | 16 | 67 | 2 | SM00216 | |
| Domain | VWF_type-D | 1.47e-03 | 16 | 67 | 2 | IPR001846 | |
| Domain | VWFD | 1.47e-03 | 16 | 67 | 2 | PS51233 | |
| Domain | VWD | 1.47e-03 | 16 | 67 | 2 | PF00094 | |
| Domain | Gal_mutarotase_SF_dom | 1.67e-03 | 17 | 67 | 2 | IPR011013 | |
| Domain | WHTH_DNA-bd_dom | 1.76e-03 | 242 | 67 | 5 | IPR011991 | |
| Domain | VWC_out | 2.08e-03 | 19 | 67 | 2 | SM00215 | |
| Domain | ADAM_spacer1 | 3.06e-03 | 23 | 67 | 2 | IPR010294 | |
| Domain | ADAM_spacer1 | 3.06e-03 | 23 | 67 | 2 | PF05986 | |
| Pathway | WP_METABOLISM_OF_ALPHALINOLENIC_ACID | 9.96e-07 | 6 | 53 | 3 | M39844 | |
| Pathway | REACTOME_BIOSYNTHESIS_OF_SPECIALIZED_PRORESOLVING_MEDIATORS_SPMS | 4.66e-05 | 19 | 53 | 3 | M27889 | |
| Pathway | WP_EICOSANOID_SYNTHESIS | 7.35e-05 | 22 | 53 | 3 | MM15961 | |
| Pathway | REACTOME_BIOSYNTHESIS_OF_SPECIALIZED_PRORESOLVING_MEDIATORS_SPMS | 7.35e-05 | 22 | 53 | 3 | MM15614 | |
| Pathway | WP_EICOSANOID_SYNTHESIS | 8.43e-05 | 23 | 53 | 3 | M39382 | |
| Pathway | WP_OXYLIPINS_PATHWAYS | 9.61e-05 | 24 | 53 | 3 | MM17249 | |
| Pathway | REACTOME_SYNTHESIS_OF_LIPOXINS_LX | 1.38e-04 | 5 | 53 | 2 | MM14859 | |
| Pathway | REACTOME_BIOSYNTHESIS_OF_E_SERIES_18_S_RESOLVINS | 1.38e-04 | 5 | 53 | 2 | MM15617 | |
| Pathway | WP_EICOSANOID_METABOLISM_VIA_LIPOOXYGENASES_LOX | 1.71e-04 | 29 | 53 | 3 | M39858 | |
| Pathway | REACTOME_SYNTHESIS_OF_LIPOXINS_LX | 2.06e-04 | 6 | 53 | 2 | M27138 | |
| Pathway | REACTOME_BIOSYNTHESIS_OF_EPA_DERIVED_SPMS | 2.06e-04 | 6 | 53 | 2 | M27890 | |
| Pathway | REACTOME_BIOSYNTHESIS_OF_EPA_DERIVED_SPMS | 2.06e-04 | 6 | 53 | 2 | MM15615 | |
| Pathway | WP_PROSTAGLANDIN_AND_LEUKOTRIENE_METABOLISM_IN_SENESCENCE_WP5122 | 2.09e-04 | 31 | 53 | 3 | M42531 | |
| Pathway | WP_EICOSANOID_METABOLISM_VIA_LIPOXYGENASES_LOX | 2.53e-04 | 33 | 53 | 3 | MM15963 | |
| Pathway | WP_MYOMETRIAL_RELAXATION_AND_CONTRACTION_PATHWAYS | 2.74e-04 | 154 | 53 | 5 | MM15974 | |
| Pathway | WP_PROSTAGLANDIN_AND_LEUKOTRIENE_METABOLISM_IN_SENESCENCE_WP5321 | 2.77e-04 | 34 | 53 | 3 | M48061 | |
| Pathway | REACTOME_SYNTHESIS_OF_12_EICOSATETRAENOIC_ACID_DERIVATIVES | 2.88e-04 | 7 | 53 | 2 | M27139 | |
| Pathway | REACTOME_SYNTHESIS_OF_12_EICOSATETRAENOIC_ACID_DERIVATIVES | 2.88e-04 | 7 | 53 | 2 | MM14860 | |
| Pathway | WP_MYOMETRIAL_RELAXATION_AND_CONTRACTION_PATHWAYS | 2.91e-04 | 156 | 53 | 5 | M39475 | |
| Pathway | REACTOME_COOPERATION_OF_PDCL_PHLP1_AND_TRIC_CCT_IN_G_PROTEIN_BETA_FOLDING | 3.86e-04 | 38 | 53 | 3 | M27656 | |
| Pathway | REACTOME_CHAPERONIN_MEDIATED_PROTEIN_FOLDING | 4.17e-04 | 39 | 53 | 3 | MM15003 | |
| Pathway | KEGG_MEDICUS_REFERENCE_GLYCOGEN_DEGRADATION_AMYLASE_ | 4.91e-04 | 9 | 53 | 2 | M47622 | |
| Pathway | WP_OMEGA6FATTY_ACIDS_IN_SENESCENCE | 1.27e-03 | 57 | 53 | 3 | M48332 | |
| Pathway | KEGG_ARACHIDONIC_ACID_METABOLISM | 1.34e-03 | 58 | 53 | 3 | M5410 | |
| Pathway | REACTOME_ARACHIDONIC_ACID_METABOLISM | 1.41e-03 | 59 | 53 | 3 | M27140 | |
| Pathway | REACTOME_ARACHIDONIC_ACID_METABOLISM | 1.55e-03 | 61 | 53 | 3 | MM14861 | |
| Pathway | WP_PATHWAYS_OF_NUCLEIC_ACID_METABOLISM_AND_INNATE_IMMUNE_SENSING | 1.61e-03 | 16 | 53 | 2 | M39846 | |
| Pubmed | 7.15e-09 | 3 | 68 | 3 | 22825379 | ||
| Pubmed | 7.15e-09 | 3 | 68 | 3 | 18346986 | ||
| Pubmed | 7.15e-09 | 3 | 68 | 3 | 15328042 | ||
| Pubmed | 7.15e-09 | 3 | 68 | 3 | 30407793 | ||
| Pubmed | 7.15e-09 | 3 | 68 | 3 | 8944751 | ||
| Pubmed | Differential contribution of lipoxygenase isozymes to nigrostriatal vulnerability. | 7.15e-09 | 3 | 68 | 3 | 23079635 | |
| Pubmed | Functional characterization of genetic enzyme variations in human lipoxygenases. | 2.86e-08 | 4 | 68 | 3 | 24282679 | |
| Pubmed | 2.86e-08 | 4 | 68 | 3 | 25698732 | ||
| Pubmed | 2.86e-08 | 4 | 68 | 3 | 19509298 | ||
| Pubmed | 2.86e-08 | 4 | 68 | 3 | 20592751 | ||
| Pubmed | Levels of expression of lipoxygenases and cyclooxygenase-2 in human breast cancer. | 2.86e-08 | 4 | 68 | 3 | 12907138 | |
| Pubmed | Neonatal imprinting of alveolar macrophages via neutrophil-derived 12-HETE. | 7.13e-08 | 5 | 68 | 3 | 36599368 | |
| Pubmed | mRNA levels of enzymes and receptors implicated in arachidonic acid metabolism in gliomas. | 1.42e-07 | 6 | 68 | 3 | 20382140 | |
| Pubmed | 1.42e-07 | 6 | 68 | 3 | 23828562 | ||
| Pubmed | 1.42e-07 | 6 | 68 | 3 | 25313597 | ||
| Pubmed | 1.42e-07 | 6 | 68 | 3 | 15897264 | ||
| Pubmed | 2.49e-07 | 7 | 68 | 3 | 17873277 | ||
| Pubmed | 3.98e-07 | 8 | 68 | 3 | 19713213 | ||
| Pubmed | Emerging role of 12/15-Lipoxygenase (ALOX15) in human pathologies. | 3.77e-06 | 2 | 68 | 2 | 30472260 | |
| Pubmed | Glutathione disulfide induces neural cell death via a 12-lipoxygenase pathway. | 3.77e-06 | 2 | 68 | 2 | 19373248 | |
| Pubmed | Relationship between lipoxygenase and human testicular cancer. | 3.77e-06 | 2 | 68 | 2 | 14767568 | |
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 30792307 | ||
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 25251155 | ||
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 15708862 | ||
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 34706241 | ||
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 19095999 | ||
| Pubmed | The Investigation of Lipoxygenases as Therapeutic Targets in Malignant Pleural Mesothelioma. | 3.77e-06 | 2 | 68 | 2 | 30941737 | |
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 21094135 | ||
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 20724598 | ||
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 10339594 | ||
| Pubmed | Enhancement role of host 12/15-lipoxygenase in melanoma progression. | 3.77e-06 | 2 | 68 | 2 | 23664097 | |
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 26811338 | ||
| Pubmed | Lipoxygenase metabolites are mediators of PTH-dependent human osteoblast growth. | 3.77e-06 | 2 | 68 | 2 | 18187376 | |
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 21220563 | ||
| Pubmed | 12/15-lipoxygenase expressed in non-epithelial cells causes airway epithelial injury in asthma. | 3.77e-06 | 2 | 68 | 2 | 23528921 | |
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 9459445 | ||
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 22089472 | ||
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 11687802 | ||
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 32760397 | ||
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 25187369 | ||
| Pubmed | 12/15-Lipoxygenase signaling in the endoplasmic reticulum stress response. | 3.77e-06 | 2 | 68 | 2 | 22215650 | |
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 19787041 | ||
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 18547056 | ||
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 18780776 | ||
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 19469483 | ||
| Pubmed | The evolutionary hypothesis of reaction specificity of mammalian ALOX15 orthologs. | 3.77e-06 | 2 | 68 | 2 | 30237084 | |
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 15111312 | ||
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 17520163 | ||
| Pubmed | Human ALOX12, but not ALOX15, is associated with BMD in white men and women. | 3.77e-06 | 2 | 68 | 2 | 16598376 | |
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 21558275 | ||
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 15681297 | ||
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 17236225 | ||
| Pubmed | Amelioration of the Alzheimer's disease phenotype by absence of 12/15-lipoxygenase. | 3.77e-06 | 2 | 68 | 2 | 20570249 | |
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 32324389 | ||
| Pubmed | Expression of lipoxygenase in human prostate cancer and growth reduction by its inhibitors. | 3.77e-06 | 2 | 68 | 2 | 15010818 | |
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 15879104 | ||
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 19497113 | ||
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 34910522 | ||
| Pubmed | Expression of lipoxygenase in human bladder carcinoma and growth inhibition by its inhibitors. | 3.77e-06 | 2 | 68 | 2 | 14532840 | |
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 29184033 | ||
| Pubmed | Resistance to type 1 diabetes induction in 12-lipoxygenase knockout mice. | 3.77e-06 | 2 | 68 | 2 | 10330425 | |
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 22516296 | ||
| Pubmed | Reciprocal regulation of 12- and 15-lipoxygenases by UV-irradiation in human keratinocytes. | 3.77e-06 | 2 | 68 | 2 | 18755188 | |
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 7576099 | ||
| Pubmed | The 12/15-lipoxygenase as an emerging therapeutic target for Alzheimer's disease. | 3.77e-06 | 2 | 68 | 2 | 25708815 | |
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 25293588 | ||
| Pubmed | Kinetic investigations of the rate-limiting step in human 12- and 15-lipoxygenase. | 3.77e-06 | 2 | 68 | 2 | 12731864 | |
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 23857581 | ||
| Pubmed | The 12/15-lipoxygenase pathway counteracts fibroblast activation and experimental fibrosis. | 3.77e-06 | 2 | 68 | 2 | 22267335 | |
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 19663136 | ||
| Pubmed | 12/15-lipoxygenase counteracts inflammation and tissue damage in arthritis. | 3.77e-06 | 2 | 68 | 2 | 19675173 | |
| Pubmed | Overexpression of 12/15-lipoxygenase increases anxiety behavior in female mice. | 3.77e-06 | 2 | 68 | 2 | 24300237 | |
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 20008149 | ||
| Pubmed | Integrative predictive model of coronary artery calcification in atherosclerosis. | 5.94e-06 | 229 | 68 | 6 | 19948975 | |
| Pubmed | 6.77e-06 | 19 | 68 | 3 | 11342430 | ||
| Pubmed | 1.13e-05 | 3 | 68 | 2 | 22279185 | ||
| Pubmed | Cochlear outer hair cell horizontal top connectors mediate mature stereocilia bundle mechanics. | 1.13e-05 | 3 | 68 | 2 | 30801007 | |
| Pubmed | Host genetic risk factors for West Nile virus infection and disease progression. | 1.13e-05 | 3 | 68 | 2 | 21935451 | |
| Pubmed | 1.13e-05 | 3 | 68 | 2 | 25143454 | ||
| Pubmed | 1.13e-05 | 3 | 68 | 2 | 19752233 | ||
| Pubmed | 1.13e-05 | 3 | 68 | 2 | 24755289 | ||
| Pubmed | 1.13e-05 | 3 | 68 | 2 | 16722930 | ||
| Pubmed | 1.13e-05 | 3 | 68 | 2 | 22637477 | ||
| Pubmed | 1.13e-05 | 3 | 68 | 2 | 22275252 | ||
| Pubmed | Role of 12/15-lipoxygenase in the expression of MCP-1 in mouse macrophages. | 1.13e-05 | 3 | 68 | 2 | 18296557 | |
| Pubmed | 1.13e-05 | 3 | 68 | 2 | 16514433 | ||
| Pubmed | 1.13e-05 | 3 | 68 | 2 | 23070608 | ||
| Pubmed | 1.13e-05 | 3 | 68 | 2 | 30944221 | ||
| Pubmed | 1.13e-05 | 3 | 68 | 2 | 25549319 | ||
| Pubmed | Hyperoxidation of ether-linked phospholipids accelerates neutrophil extracellular trap formation. | 1.13e-05 | 3 | 68 | 2 | 29167447 | |
| Pubmed | 1.13e-05 | 3 | 68 | 2 | 19822654 | ||
| Pubmed | 1.13e-05 | 3 | 68 | 2 | 10521509 | ||
| Pubmed | Oxidative metabolism of a fatty acid amide hydrolase-regulated lipid, arachidonoyltaurine. | 1.13e-05 | 3 | 68 | 2 | 18311922 | |
| Pubmed | 1.13e-05 | 3 | 68 | 2 | 24981230 | ||
| Pubmed | Effects of silencing leukocyte-type 12/15-lipoxygenase using short interfering RNAs. | 1.13e-05 | 3 | 68 | 2 | 15576842 | |
| Pubmed | Stereocilin-deficient mice reveal the origin of cochlear waveform distortions. | 2.25e-05 | 4 | 68 | 2 | 18849963 | |
| Pubmed | 2.25e-05 | 4 | 68 | 2 | 9518531 | ||
| Pubmed | 2.25e-05 | 4 | 68 | 2 | 1570320 | ||
| Pubmed | R7BP augments the function of RGS7*Gbeta5 complexes by a plasma membrane-targeting mechanism. | 2.25e-05 | 4 | 68 | 2 | 16867977 | |
| Pubmed | 2.25e-05 | 4 | 68 | 2 | 12122008 | ||
| Interaction | RGS7BP interactions | 1.94e-06 | 8 | 67 | 3 | int:RGS7BP | |
| Cytoband | 19q13.3 | 2.42e-04 | 82 | 67 | 3 | 19q13.3 | |
| Cytoband | 15q15.3 | 6.16e-04 | 25 | 67 | 2 | 15q15.3 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1p35 | 1.08e-03 | 137 | 67 | 3 | chr1p35 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr19q13 | 1.75e-03 | 1192 | 67 | 7 | chr19q13 | |
| GeneFamily | Arachidonate lipoxygenases | 3.07e-07 | 6 | 46 | 3 | 407 | |
| GeneFamily | Regulators of G-protein signaling | 1.99e-05 | 21 | 46 | 3 | 720 | |
| GeneFamily | Transmembrane channel likes | 1.76e-04 | 8 | 46 | 2 | 1135 | |
| GeneFamily | Hyalectan proteoglycans|V-set domain containing|Sushi domain containing|C-type lectin domain containing | 4.10e-04 | 57 | 46 | 3 | 1179 | |
| ToppCell | Control-Epithelial_cells-Airway_mucous|Control / group, cell type (main and fine annotations) | 1.29e-08 | 183 | 68 | 7 | 15d24a4fb1ffe6cbafbd54fcd7dde9ddcfbe03b2 | |
| ToppCell | Parenchymal-NucSeq-Immune_Myeloid-Macrophage_other-Macro_AW_CX3CR1|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.22e-08 | 198 | 68 | 7 | 732a43061d75bc5e1cf23f5056b72cd10c926668 | |
| ToppCell | COVID-19-Heart-CM_+_Macrophage|Heart / Disease (COVID-19 only), tissue and cell type | 2.40e-07 | 170 | 68 | 6 | 4232fe937909f93d3736988c707b8f95ce993398 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.61e-07 | 190 | 68 | 6 | 2fdc024d3d673a0134b74b4c5a63afe924995730 | |
| ToppCell | Bronchial-10x5prime-Immune_Myeloid-Macrophage_other-Macro_AW_CX3CR1|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 5.54e-07 | 196 | 68 | 6 | b15812354128c12a588d79ef449d787e74835f3b | |
| ToppCell | 367C-Myeloid-Macrophage-FABP4+_Macrophage_2|367C / Donor, Lineage, Cell class and subclass (all cells) | 4.11e-06 | 156 | 68 | 5 | 1a0e081284a99c1b345990775015b8a2fa469496 | |
| ToppCell | 3'-Adult-SmallIntestine-Epithelial-epithelial_progenitor_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.89e-06 | 168 | 68 | 5 | 4e2e4c88ada772e9ba6e72c9ae3a05c063e93318 | |
| ToppCell | 3'-Adult-SmallIntestine-Epithelial-epithelial_progenitor_cell-TA|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.89e-06 | 168 | 68 | 5 | ee4dab089adef2f47a9d39d91934523331a8b81c | |
| ToppCell | nucseq-Epithelial-Epithelial_Glandular|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 8.02e-06 | 179 | 68 | 5 | 859cd8ee414ad6207c046ada2e655e49322dd01c | |
| ToppCell | nucseq-Epithelial-Epithelial_Glandular-Goblet|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 8.24e-06 | 180 | 68 | 5 | 3dc80bc636bf0e6ffc9762853132a9fe59fd1f66 | |
| ToppCell | nucseq-Epithelial-Epithelial_Glandular-Goblet-Goblet|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 8.24e-06 | 180 | 68 | 5 | 668a2d8e1d5a390309d5eb62c836f5903144bea9 | |
| ToppCell | P03-Endothelial-lymphatic_endothelial_cell-endothelial_cell_of_lymphatic_vessel|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 8.93e-06 | 183 | 68 | 5 | 89727b4f65949ed2dce9d2e0228c79fe4280230c | |
| ToppCell | P03-Endothelial-lymphatic_endothelial_cell|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 8.93e-06 | 183 | 68 | 5 | 113e6d8d4bb271be984af06cd6c22b180425dcfc | |
| ToppCell | facs-Liver-Non-hepatocytes-24m-Endothelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.93e-06 | 183 | 68 | 5 | ebe369dc80c4fbf8f4dbe947147f8c47507ffb60 | |
| ToppCell | Control-Epithelial_cells-Airway_goblet|Control / group, cell type (main and fine annotations) | 9.17e-06 | 184 | 68 | 5 | d92a71441e4e19f8c301999d8186f8e48e3cd162 | |
| ToppCell | Multiple_Sclerosis-Other-Platelet|Multiple_Sclerosis / Disease, Lineage and Cell Type | 9.41e-06 | 185 | 68 | 5 | 2e480dde7ecb2f88ff005f86ef732a1cf0209d45 | |
| ToppCell | 368C-Myeloid-Macrophage-FABP4+_Macrophage_3|368C / Donor, Lineage, Cell class and subclass (all cells) | 9.66e-06 | 186 | 68 | 5 | ddfadd43efeac3b3e6b7062590cc2b8f2f2db2ab | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.66e-06 | 186 | 68 | 5 | 4780af76237d7af2abbe2d8d5530cdf53e3ed0b7 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.66e-06 | 186 | 68 | 5 | a95744b8649096bd7cfc3591a02841fa411085b3 | |
| ToppCell | Healthy/Control-Platelet|World / Disease group and Cell class | 1.02e-05 | 188 | 68 | 5 | 552077e4597d0956f4d8c40c9de8f109e87cb857 | |
| ToppCell | 368C-Epithelial_cells-Epithelial-E_(AT2)|368C / Donor, Lineage, Cell class and subclass (all cells) | 1.04e-05 | 189 | 68 | 5 | 6f2322d017b74a1757c81d6e06f50ead8c3dd0cc | |
| ToppCell | mild_COVID-19-Platelet|World / disease group, cell group and cell class (v2) | 1.04e-05 | 189 | 68 | 5 | 038ec3c266b89416bb5b774ba522d916394961da | |
| ToppCell | Healthy/Control-Platelet|Healthy/Control / Disease group and Cell class | 1.04e-05 | 189 | 68 | 5 | 3de7f8d8b8451ed9a146cce499552e9a060e9099 | |
| ToppCell | 368C-Epithelial_cells-Epithelial-E_(AT2)-|368C / Donor, Lineage, Cell class and subclass (all cells) | 1.04e-05 | 189 | 68 | 5 | 926b5fa3064b501a57ba78583e8af33532add455 | |
| ToppCell | PBMC-Mild-Hematopoietic-Platelet-Platelet-plt_1|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.07e-05 | 190 | 68 | 5 | b719061be370ffc293854f1f6e526bf33cd2f442 | |
| ToppCell | COVID-19_Moderate-Platelet|World / disease group, cell group and cell class | 1.07e-05 | 190 | 68 | 5 | 6e4f4af5ba185bb022753881a26a269a544bb59b | |
| ToppCell | 368C-Epithelial_cells|368C / Donor, Lineage, Cell class and subclass (all cells) | 1.07e-05 | 190 | 68 | 5 | 459811e88d3001816c2d89034e0921c24918c17f | |
| ToppCell | PBMC-Mild-Hematopoietic-Platelet-Platelet-plt_1|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.07e-05 | 190 | 68 | 5 | 427038bae9c7b3a9441c8d59ace69da74e9d37bf | |
| ToppCell | PBMC-Severe-Hematopoietic-Platelet-Platelet-plt_1|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.10e-05 | 191 | 68 | 5 | 7da172553ed6df4a0c34ecd55665a9598b5071a5 | |
| ToppCell | PBMC-Severe-Hematopoietic-Platelet-Platelet-plt_1|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.10e-05 | 191 | 68 | 5 | 1a1bf85bc77bf093a0ac2cb9eabaeac820a7b93e | |
| ToppCell | mild_COVID-19-Platelet|mild_COVID-19 / disease group, cell group and cell class (v2) | 1.10e-05 | 191 | 68 | 5 | 968e2d48969884dd21b8a87f199af94a7410b0dd | |
| ToppCell | Adult-Immune-alveolar_macrophage_(MARCO_positive)-D122|Adult / Lineage, Cell type, age group and donor | 1.15e-05 | 193 | 68 | 5 | cc1b6d3bf56e4a88f6fe23dd036a83cf5538c958 | |
| ToppCell | 343B-Epithelial_cells-Epithelial-G_(Club-Clara_cells)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.15e-05 | 193 | 68 | 5 | 8ede7038a222c7e7ecaf7e86520823cf606cbee7 | |
| ToppCell | 343B-Epithelial_cells-Epithelial-G_(Club-Clara_cells)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.15e-05 | 193 | 68 | 5 | 0e7d7adfaa7191e34038fcda6677561ae13934eb | |
| ToppCell | 367C-Myeloid-Macrophage-FABP4+_Macrophage|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.18e-05 | 194 | 68 | 5 | 40c91ed945bd5990a0dbf2090d37a660b19aaab2 | |
| ToppCell | Bronchial-NucSeq-Immune_Myeloid-Macrophage_other-Macro_AW_CX3CR1|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.27e-05 | 197 | 68 | 5 | 0a404b4494a2246d5a92299235056f0fda4d2b48 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.27e-05 | 197 | 68 | 5 | adb4e27d73ae2e6a39d212c0ead3ac0ad62d9131 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Myeloid-Macrophage-macrophage,_alveolar-Macro_c1-C1QC|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.31e-05 | 198 | 68 | 5 | 579a22199643440b98e381147779ced630d4ed66 | |
| ToppCell | Bronchial_Brush-Immune-Luminal_Macrophages|Immune / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.31e-05 | 198 | 68 | 5 | 77f41f0e0895b7c732bab1fd2e047f2ed31cbd9d | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Myeloid|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.31e-05 | 198 | 68 | 5 | e1a0c809302a3b304775bd708201ad412a98d711 | |
| ToppCell | Control-Epithelial_cells-Cycling_epithelial|Control / group, cell type (main and fine annotations) | 1.31e-05 | 198 | 68 | 5 | b43290d2f8ca45b4a21cb6dbdf1b4384897672e0 | |
| ToppCell | Tracheal-10x3prime_v2-Immune_Myeloid-Macrophage_other-Macro_AW_CX3CR1|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.34e-05 | 199 | 68 | 5 | 514dbf128b6832b1cbd65be023d4fe02400e8dec | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_anti-infl|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.34e-05 | 199 | 68 | 5 | de9c1c801eb34faf01760df07d5ff6bbd561e152 | |
| ToppCell | Tracheal-NucSeq-Immune_Myeloid-Macrophage_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.34e-05 | 199 | 68 | 5 | 98c0d57c247d39bc771d81f4387f8dd01222628e | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Myeloid-TAM-BDM|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.34e-05 | 199 | 68 | 5 | 0d447ca1a77120aac068857ff0ddc2ed6942ed3e | |
| ToppCell | Tracheal-NucSeq-Immune_Myeloid-Macrophage_alveolar-Macro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.34e-05 | 199 | 68 | 5 | b818d46a39c8782188d82dc8931b8eec9d549dd1 | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_anti-infl-Z|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.34e-05 | 199 | 68 | 5 | 45e2f44a0ed39cb9ba061a03874c1fe746856c2d | |
| ToppCell | Parenchymal-10x3prime_v2-Immune_Myeloid-Macrophage_other-Macrophage_intermediate|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.34e-05 | 199 | 68 | 5 | ccd473accf2205c120c0d32031619e421558a861 | |
| ToppCell | COVID-19-COVID-19_Mild-Others|COVID-19_Mild / Disease, condition lineage and cell class | 1.37e-05 | 200 | 68 | 5 | ecf94be4bb961ec343471547f2ea327bc6f709f4 | |
| ToppCell | MS-Multiple_Sclerosis-Others-Platelet|Multiple_Sclerosis / Disease, condition lineage and cell class | 1.37e-05 | 200 | 68 | 5 | 263d956136747c209951b4358f2e1672a21d8eef | |
| ToppCell | COVID-19-COVID-19_Mild-Others-Platelet|COVID-19_Mild / Disease, condition lineage and cell class | 1.37e-05 | 200 | 68 | 5 | bf5e7a36d6ed44a30f906702b40ace3ecd423398 | |
| ToppCell | Tracheal-10x5prime-Immune_Myeloid-Macrophage_other-Macro_AW_CX3CR1|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.37e-05 | 200 | 68 | 5 | 27f498bcd706d0751091662996795b5270e46f14 | |
| ToppCell | (51)_cDC1|World / shred on Cell_type and subtype | 1.51e-05 | 204 | 68 | 5 | a8cf4180c406674b7541917d1fc6127686ba5f8a | |
| ToppCell | PBMC-Control-Myeloid-Neutrophil-Neutrophil-Neu_1|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.62e-05 | 142 | 68 | 4 | 191a13bba143ecdfc2bfd797c3ac191481388298 | |
| ToppCell | PBMC-Control-Myeloid-Neutrophil-Neutrophil-Neu_1|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 6.80e-05 | 143 | 68 | 4 | b405dba9a83a99cc7b53ce71772bc52a0bbb0d4e | |
| ToppCell | Hippocampus-Neuronal-Excitatory-eN1(Slc17a7)-eN1_2|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 7.57e-05 | 147 | 68 | 4 | 8f725ff8fb4ced5db2643e80669d3f7945b820ab | |
| ToppCell | PND10-Immune-Immune_Myeloid-Granulocytic|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.98e-05 | 149 | 68 | 4 | c9334f319a0c943268e54b6f0c9446736172c3a9 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.84e-05 | 153 | 68 | 4 | 9b6675ace8a83c8d446b722301d0ec4e6840f3fc | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Myeloid-Dendritic-conventional_dendritic_cell|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.84e-05 | 153 | 68 | 4 | ee6f4770c6e35d59bdeec5b0ecb10119fa8c3ca5 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Myeloid-Dendritic|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.84e-05 | 153 | 68 | 4 | a35149a0c8b4ec9ad27cc4b3d34fba3b8714a6a2 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Myeloid-Dendritic-conventional_dendritic_cell-DC_c2-CD1C|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.84e-05 | 153 | 68 | 4 | 90cd6efda83c0b4b80eae2c90e7ff45dfd936dc2 | |
| ToppCell | PND07-Immune-Immune_Myeloid-Granulocytic|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.07e-05 | 154 | 68 | 4 | f92d83c5f8b532fe5624f1cd352632f543d96ea9 | |
| ToppCell | PND07-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.53e-05 | 156 | 68 | 4 | 1928c86deb3bcd01db4ae76919a351066aadb39a | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.77e-05 | 157 | 68 | 4 | 2c5295043611bac7dfa4aef2146681bce4a33a8f | |
| ToppCell | LPS-antiTNF-Endothelial-Mes-Like|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.00e-04 | 158 | 68 | 4 | 50df52d64d07178975563abd98ce4fddb9f2f7ef | |
| ToppCell | 368C-Myeloid-Macrophage-FABP4+_Macrophage_2|368C / Donor, Lineage, Cell class and subclass (all cells) | 1.05e-04 | 160 | 68 | 4 | ac3f56f8ab8efd11c4b4868a828db05c23ac762f | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Epithelial-Epcam____brush_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.10e-04 | 162 | 68 | 4 | de0fde4310a56dc96bfc134c44d104993526d9bc | |
| ToppCell | normal_Lung-Epithelial_cells-Undetermined|normal_Lung / Location, Cell class and cell subclass | 1.16e-04 | 164 | 68 | 4 | fa2dae15b38cb8f9642dbf00549beec8ee19e9bb | |
| ToppCell | facs-Marrow-T_cells-18m-Myeloid-basophil|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.21e-04 | 166 | 68 | 4 | c22b0f3bf990d94b615a3aacee5de548da2db628 | |
| ToppCell | facs-Marrow-T_cells-18m-Myeloid-basophil|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.21e-04 | 166 | 68 | 4 | 0975fc165bcc7e85f053d9d0244fffe407c23571 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Epithelial-neuro-epithelial-K_cells_(GIP+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.21e-04 | 166 | 68 | 4 | afba41e15478053f11815acf568d29187de75492 | |
| ToppCell | droplet-Kidney-nan-18m-Epithelial-Epcam____brush_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.24e-04 | 167 | 68 | 4 | ed7e785dcd25777f64e0c2596ada4f5a5ea17121 | |
| ToppCell | droplet-Kidney-nan-3m-Epithelial-Epcam____brush_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.24e-04 | 167 | 68 | 4 | 40d102e01ccbc7262d00fafd59ca5234909009cb | |
| ToppCell | 3'-Distal_airway-Epithelial-Epithelial_transtional-secretory-bronchial_goblet_cell-Goblet_(bronchial)-Goblet_(bronchial)_L.0.4.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.27e-04 | 168 | 68 | 4 | b275e951ff7109e36da22fc17bd4516f9b9432c4 | |
| ToppCell | 3'-Distal_airway-Epithelial-Epithelial_transtional-secretory-bronchial_goblet_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.27e-04 | 168 | 68 | 4 | 0757a5af953901a8faed5774ffec4755fc9c0a6e | |
| ToppCell | Sigmoid-Macrophage-Macrophage|Macrophage / Region, Cell class and subclass | 1.27e-04 | 168 | 68 | 4 | bb16e135b6ae0d66615420b61edd6f62f2a3233c | |
| ToppCell | 3'-Distal_airway-Epithelial-Epithelial_transtional-secretory-bronchial_goblet_cell-Goblet_(bronchial)|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.27e-04 | 168 | 68 | 4 | a0dbe2ee697e29b32aa5f8326445e067ff66c154 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Epithelial-Epcam____brush_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.27e-04 | 168 | 68 | 4 | 35ce3b2b9c9997d4c101da5949c7271d6a6b8f12 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial-Lgr5+_amplifying_undifferentiated_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.27e-04 | 168 | 68 | 4 | d69452e2cfeb74023b5cf3d09064d7dcad0008ec | |
| ToppCell | 390C-Myeloid-Macrophage-M2-like_Macrophage_(MARCO_negative)|390C / Donor, Lineage, Cell class and subclass (all cells) | 1.30e-04 | 169 | 68 | 4 | 2c851b2703c7b8b656026f996f5fc027e4a79b36 | |
| ToppCell | droplet-Kidney-nan-18m-Epithelial-brush_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.30e-04 | 169 | 68 | 4 | f00741203efa0b948db7223ee8c19bdd0918258a | |
| ToppCell | wk_15-18-Hematologic-Meg-ery-Megakaryocyte|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.30e-04 | 169 | 68 | 4 | d571e84e01e3316748d4407ed98881b17484e035 | |
| ToppCell | wk_20-22-Hematologic-Meg-ery-Megakaryocyte|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 1.33e-04 | 170 | 68 | 4 | eace4dd09cdbde0fa40a6aa0f3dba1114d0ce475 | |
| ToppCell | PND07-Immune-Immune_Myeloid-Granulocytic-Basophil|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.33e-04 | 170 | 68 | 4 | bca78719c17355772ad6c53ee75e459faf1d089f | |
| ToppCell | PND07-Immune-Immune_Myeloid-Granulocytic-Basophil-Basophil_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.33e-04 | 170 | 68 | 4 | 40d863554ec98ae43f76511c1112859688846613 | |
| ToppCell | droplet-Kidney-nan-21m-Epithelial-brush_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.36e-04 | 171 | 68 | 4 | 007f148f4611ea1826edfa9f91ced36541ad9f5a | |
| ToppCell | droplet-Kidney-nan-21m-Epithelial-Epcam____brush_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.36e-04 | 171 | 68 | 4 | 8e7223ba447947cdf4e1c82a52fd90439cf3d8f6 | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.36e-04 | 171 | 68 | 4 | 4ede831aed364cb5271f49a8b09bb6d0452f9b35 | |
| ToppCell | metastatic_Lymph_Node-Myeloid_cells-Microglia/Mac|metastatic_Lymph_Node / Location, Cell class and cell subclass | 1.39e-04 | 172 | 68 | 4 | f673a2e697b46e7cfa4186cb3fb2b98e3c83703e | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L5-6_FEZF2_ANKRD20A1|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.39e-04 | 172 | 68 | 4 | ddecdb1a0791296929790f78b49008f51a130f8b | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Epithelial-neuro-epithelial|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.42e-04 | 173 | 68 | 4 | 46ed379571385684145b5cb6dd4ae340ac546e64 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.42e-04 | 173 | 68 | 4 | 95c723b09254ae7131fe5ba0841472502e83269b | |
| ToppCell | facs-Marrow-Granulocytes-3m-Myeloid-basophil|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.48e-04 | 175 | 68 | 4 | 1b35acece23712ab7e3f92d9d68266efd38b3ef5 | |
| ToppCell | droplet-Liver-Npc-21m-Lymphocytic|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.48e-04 | 175 | 68 | 4 | 046e841811b22c39f80a9752f3223c1906de6f20 | |
| ToppCell | Dendritic_Cells-IPF_02|World / lung cells shred on cell class, cell subclass, sample id | 1.48e-04 | 175 | 68 | 4 | 584290a51f9975782a5ac8c6ad67c778d8323f8c | |
| ToppCell | facs-Kidney-nan-18m-Epithelial-epithelial_cell_of_proximal_tubule|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.48e-04 | 175 | 68 | 4 | 076ad81d6cbeea5512393d192af3ab5aa1f82975 | |
| ToppCell | droplet-Heart-HEART-1m-Hematologic-leukocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.48e-04 | 175 | 68 | 4 | a2fed97cf8d28f9936fe791e5e8c43d2430330c9 | |
| ToppCell | facs-Marrow-Granulocytes-3m-Myeloid-basophil|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.48e-04 | 175 | 68 | 4 | a9f88054e2c28d604c65ed785f63021aadb7f4c8 | |
| ToppCell | facs-Kidney-nan-18m-Epithelial-epithelial_cell_of_proximal_tubule|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.48e-04 | 175 | 68 | 4 | 445ccb9744a3a9ff37164c532afbe769d306b6c8 | |
| ToppCell | 10x5'-lymph-node_spleen-Hematopoietic_Erythro-Mega|lymph-node_spleen / Manually curated celltypes from each tissue | 1.48e-04 | 175 | 68 | 4 | 5ca3369ce2c2bb88ba097260195aecd67cec1a3a | |
| Drug | sinensetin | 1.14e-07 | 16 | 66 | 4 | CID000145659 | |
| Drug | N-(3-phenoxycinnamyl)acetohydroxamic acid | 2.32e-07 | 5 | 66 | 3 | ctd:C056614 | |
| Drug | artonin E | 2.32e-07 | 5 | 66 | 3 | CID005481962 | |
| Drug | isamoxole | 4.62e-07 | 6 | 66 | 3 | CID000042118 | |
| Drug | 1-oleoyl-2-DHA-PC | 4.62e-07 | 6 | 66 | 3 | CID006438829 | |
| Drug | CPHU | 4.62e-07 | 6 | 66 | 3 | CID000124471 | |
| Drug | BW A797C | 4.62e-07 | 6 | 66 | 3 | CID006439067 | |
| Drug | octadecadienoic acid | 5.47e-07 | 23 | 66 | 4 | CID005312457 | |
| Drug | pinolenic acid | 7.78e-07 | 25 | 66 | 4 | CID005312493 | |
| Drug | 12-IODE | 8.08e-07 | 7 | 66 | 3 | CID006450050 | |
| Drug | AC1L3WDO | 9.17e-07 | 26 | 66 | 4 | CID000123344 | |
| Drug | sulfapyridine | 1.07e-06 | 27 | 66 | 4 | CID000005336 | |
| Drug | colneleic acid | 1.29e-06 | 8 | 66 | 3 | CID006441681 | |
| Drug | Cgs 22745 | 1.29e-06 | 8 | 66 | 3 | CID006439321 | |
| Drug | TEI-8005 | 1.29e-06 | 8 | 66 | 3 | CID006438655 | |
| Drug | htyA | 1.29e-06 | 8 | 66 | 3 | CID000152267 | |
| Drug | CDNQ | 1.29e-06 | 8 | 66 | 3 | CID000126468 | |
| Drug | Perhexiline maleate [6724-53-4]; Up 200; 10.2uM; PC3; HT_HG-U133A | 1.77e-06 | 199 | 66 | 7 | 5081_UP | |
| Drug | 14,15-leukotriene A4 | 1.93e-06 | 9 | 66 | 3 | CID006439604 | |
| Drug | octadeca-9,12-dien-1-ol | 1.93e-06 | 9 | 66 | 3 | CID000068168 | |
| Drug | U-56467 | 1.93e-06 | 9 | 66 | 3 | CID006439532 | |
| Drug | 8,15-diHPETE | 1.93e-06 | 9 | 66 | 3 | CID005283181 | |
| Drug | T 0757 | 1.93e-06 | 9 | 66 | 3 | CID006439291 | |
| Drug | 13-hydroxylinoleic acid | 1.93e-06 | 9 | 66 | 3 | CID006438633 | |
| Drug | AC1NSXHC | 1.93e-06 | 9 | 66 | 3 | CID005371969 | |
| Drug | U-66,855 | 1.93e-06 | 9 | 66 | 3 | CID000127235 | |
| Drug | ODYA | 1.93e-06 | 9 | 66 | 3 | CID000001931 | |
| Drug | A-78773 | 1.93e-06 | 9 | 66 | 3 | CID000071460 | |
| Drug | S 19812 | 1.93e-06 | 9 | 66 | 3 | CID005744460 | |
| Drug | AC1L1TSE | 2.11e-06 | 72 | 66 | 5 | CID000060719 | |
| Drug | (Z)-7-[(1R,2R,3R)-2-[(1E,3S,5Z)-3-hydroxyocta-1,5-dienyl]-3-methyl-5-oxocyclopentyl]hept-5-enoic acid | 2.47e-06 | 33 | 66 | 4 | CID009548573 | |
| Drug | EP 10045 | 2.75e-06 | 10 | 66 | 3 | CID000127575 | |
| Drug | 9-HPODE | 2.75e-06 | 10 | 66 | 3 | CID000001928 | |
| Drug | 1,4-pentadiene | 2.75e-06 | 10 | 66 | 3 | CID000011587 | |
| Drug | LTE5 | 3.78e-06 | 11 | 66 | 3 | CID006439533 | |
| Drug | acetone phenylhydrazone | 3.78e-06 | 11 | 66 | 3 | CID000066026 | |
| Drug | Ity A | 3.78e-06 | 11 | 66 | 3 | CID000188274 | |
| Drug | BW A137C | 3.78e-06 | 11 | 66 | 3 | CID000129265 | |
| Drug | nonenal | 5.02e-06 | 12 | 66 | 3 | CID003015503 | |
| Drug | eicosa-8,11,14-trienoic acid | 5.71e-06 | 88 | 66 | 5 | CID000003011 | |
| Drug | AC1NR1Q2 | 6.52e-06 | 13 | 66 | 3 | CID005283190 | |
| Drug | CV-6504 | 6.52e-06 | 13 | 66 | 3 | CID000093543 | |
| Drug | AC1L1BGZ | 6.52e-06 | 13 | 66 | 3 | CID000001435 | |
| Drug | 9-HETE | 6.52e-06 | 13 | 66 | 3 | CID000001926 | |
| Drug | hypolaetin | 6.52e-06 | 13 | 66 | 3 | CID005281648 | |
| Drug | ICI207968 | 6.52e-06 | 13 | 66 | 3 | CID000129095 | |
| Drug | AC1O4E1A | 6.52e-06 | 13 | 66 | 3 | CID006365736 | |
| Drug | stearic acid | 6.78e-06 | 159 | 66 | 6 | CID000005281 | |
| Drug | BAY X 1005 | 7.30e-06 | 43 | 66 | 4 | CID000123723 | |
| Drug | acetone phenylhydrazone | 8.28e-06 | 2 | 66 | 2 | ctd:C045543 | |
| Drug | AC1L4H9B | 8.28e-06 | 2 | 66 | 2 | CID000157032 | |
| Drug | AC1NR1LB | 8.28e-06 | 14 | 66 | 3 | CID005283131 | |
| Drug | Ro 19-3704 | 8.28e-06 | 14 | 66 | 3 | CID000129364 | |
| Drug | YS06 | 8.28e-06 | 14 | 66 | 3 | CID000484586 | |
| Drug | oxphaman | 8.28e-06 | 14 | 66 | 3 | CID005464022 | |
| Drug | timegadine | 8.28e-06 | 14 | 66 | 3 | CID000068902 | |
| Drug | 5-HEPE | 8.28e-06 | 14 | 66 | 3 | CID000001766 | |
| Drug | 17-HdoHE | 8.28e-06 | 14 | 66 | 3 | CID006439179 | |
| Drug | flurbiprofen | 1.03e-05 | 171 | 66 | 6 | CID000003394 | |
| Drug | 8R-HpETE | 1.03e-05 | 15 | 66 | 3 | CID005283170 | |
| Drug | Hex-3-enyl acetate | 1.03e-05 | 15 | 66 | 3 | CID000015574 | |
| Drug | 8(S),15(S)-diHETE | 1.03e-05 | 15 | 66 | 3 | CID000001897 | |
| Drug | 13-HpOTrE | 1.03e-05 | 15 | 66 | 3 | CID005282866 | |
| Drug | AC1NR1M2 | 1.27e-05 | 16 | 66 | 3 | CID005283140 | |
| Drug | 12R-HETrE | 1.27e-05 | 16 | 66 | 3 | CID005283149 | |
| Drug | peroxylinolenic acid | 1.27e-05 | 16 | 66 | 3 | CID006439905 | |
| Drug | hex-3-enal | 1.27e-05 | 16 | 66 | 3 | CID000023234 | |
| Drug | butylethanolamine | 1.27e-05 | 16 | 66 | 3 | CID000249006 | |
| Drug | A63162 | 1.27e-05 | 16 | 66 | 3 | CID000121876 | |
| Drug | 5,15-diHETE | 1.54e-05 | 17 | 66 | 3 | CID005283158 | |
| Drug | cirsiliol | 1.54e-05 | 17 | 66 | 3 | CID000160237 | |
| Drug | 2 CS | 1.54e-05 | 17 | 66 | 3 | CID000060923 | |
| Drug | 7,7-dimethyleicosadienoic acid | 1.54e-05 | 17 | 66 | 3 | CID000001877 | |
| Drug | FPL 57231 | 1.84e-05 | 18 | 66 | 3 | CID000122212 | |
| Drug | diphenyl disulfide | 1.84e-05 | 18 | 66 | 3 | CID000013436 | |
| Drug | 3-nonenal | 1.84e-05 | 18 | 66 | 3 | CID005283336 | |
| Drug | BW540C | 1.84e-05 | 18 | 66 | 3 | CID000134372 | |
| Drug | AC1O5PL5 | 1.84e-05 | 18 | 66 | 3 | CID006438380 | |
| Drug | AC1L1X0Y | 2.29e-05 | 117 | 66 | 5 | CID000062388 | |
| Drug | NSC186061 | 2.38e-05 | 118 | 66 | 5 | CID000004163 | |
| Drug | dithiol | 2.48e-05 | 3 | 66 | 2 | ctd:C004848 | |
| Drug | Acetyl benzyl disulfide | 2.48e-05 | 3 | 66 | 2 | CID000193413 | |
| Drug | 1,3-dimethylthymine | 2.48e-05 | 3 | 66 | 2 | CID000078112 | |
| Drug | 4,5-Dihydro-1-(3-(trifluoromethyl)phenyl)-1H-pyrazol-3-amine | 2.48e-05 | 3 | 66 | 2 | ctd:D015772 | |
| Drug | 4-(3-chlorophenyl)thiosemicarbazide | 2.48e-05 | 3 | 66 | 2 | CID000707050 | |
| Drug | 13(R)-hydroxy-octadeca-(9Z,11E,15Z)-trienoic acid | 2.48e-05 | 3 | 66 | 2 | CID000643726 | |
| Drug | N2 76 | 2.48e-05 | 3 | 66 | 2 | CID000192216 | |
| Drug | L-651,392 | 2.56e-05 | 20 | 66 | 3 | CID000122182 | |
| Drug | TMK777 | 2.56e-05 | 20 | 66 | 3 | CID006438911 | |
| Drug | AC1L2P35 | 2.56e-05 | 20 | 66 | 3 | CID000125736 | |
| Drug | AC1O5S1P | 2.98e-05 | 21 | 66 | 3 | CID006439617 | |
| Drug | AC1NRAUB | 2.98e-05 | 21 | 66 | 3 | CID005288098 | |
| Drug | 20-carboxyleukotriene B4 | 2.98e-05 | 21 | 66 | 3 | CID000001588 | |
| Drug | AC1L1FO2 | 2.98e-05 | 21 | 66 | 3 | CID000003321 | |
| Drug | BM 13.177 | 3.44e-05 | 22 | 66 | 3 | CID000051550 | |
| Drug | 5,8,11-eicosatrienoic acid | 3.44e-05 | 22 | 66 | 3 | CID000004028 | |
| Drug | CGS 8515 | 3.44e-05 | 22 | 66 | 3 | CID000163944 | |
| Drug | diethylcarbamazine | 3.44e-05 | 22 | 66 | 3 | CID000003052 | |
| Drug | L-656,224 | 3.95e-05 | 23 | 66 | 3 | CID000128132 | |
| Drug | AC1NSYHD | 3.95e-05 | 23 | 66 | 3 | CID005319705 | |
| Disease | autosomal recessive nonsyndromic deafness 16 (implicated_via_orthology) | 5.08e-06 | 2 | 67 | 2 | DOID:0110471 (implicated_via_orthology) | |
| Disease | COVID-19 symptoms measurement | 6.95e-05 | 35 | 67 | 3 | EFO_0600019 | |
| Disease | pancreatic cancer (is_marker_for) | 8.40e-05 | 101 | 67 | 4 | DOID:1793 (is_marker_for) | |
| Disease | congestive heart failure (biomarker_via_orthology) | 1.05e-04 | 107 | 67 | 4 | DOID:6000 (biomarker_via_orthology) | |
| Disease | biliary tract benign neoplasm (is_marker_for) | 1.06e-04 | 7 | 67 | 2 | DOID:0050625 (is_marker_for) | |
| Disease | transverse temporal cortex volume measurement | 2.26e-04 | 10 | 67 | 2 | EFO_0010336 | |
| Disease | cholangiocarcinoma (is_marker_for) | 4.22e-04 | 64 | 67 | 3 | DOID:4947 (is_marker_for) | |
| Disease | gastric ulcer (implicated_via_orthology) | 4.54e-04 | 14 | 67 | 2 | DOID:10808 (implicated_via_orthology) | |
| Disease | response to methotrexate, aspartate aminotransferase measurement | 4.54e-04 | 14 | 67 | 2 | EFO_0004736, GO_0031427 | |
| Disease | Diabetic Asymmetric Polyneuropathy | 4.54e-04 | 14 | 67 | 2 | C0393835 | |
| Disease | Diabetic Neuralgia | 4.54e-04 | 14 | 67 | 2 | C0751074 | |
| Disease | Diabetic Neuropathies | 4.54e-04 | 14 | 67 | 2 | C0011882 | |
| Disease | Asymmetric Diabetic Proximal Motor Neuropathy | 4.54e-04 | 14 | 67 | 2 | C0271674 | |
| Disease | Symmetric Diabetic Proximal Motor Neuropathy | 4.54e-04 | 14 | 67 | 2 | C0271673 | |
| Disease | Diabetic Mononeuropathy | 4.54e-04 | 14 | 67 | 2 | C0271678 | |
| Disease | Diabetic Autonomic Neuropathy | 4.54e-04 | 14 | 67 | 2 | C0271686 | |
| Disease | Diabetic Amyotrophy | 4.54e-04 | 14 | 67 | 2 | C0271685 | |
| Disease | Diabetic Polyneuropathies | 4.54e-04 | 14 | 67 | 2 | C0271680 | |
| Disease | COVID-19, osteoarthritis | 9.40e-04 | 20 | 67 | 2 | MONDO_0005178, MONDO_0100096 | |
| Disease | serum gamma-glutamyl transferase measurement | 1.07e-03 | 914 | 67 | 8 | EFO_0004532 | |
| Disease | hepatocellular carcinoma (biomarker_via_orthology) | 1.93e-03 | 108 | 67 | 3 | DOID:684 (biomarker_via_orthology) | |
| Disease | 1,5 anhydroglucitol measurement | 1.98e-03 | 29 | 67 | 2 | EFO_0008009 | |
| Disease | respiratory failure, COVID-19 | 1.98e-03 | 29 | 67 | 2 | EFO_0009686, MONDO_0100096 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SGNRTWYPEVPKCEW | 526 | P04003 | |
| PWVEYWEFLGCFVDL | 576 | Q86XL3 | |
| PGWPGFYKDALSCAW | 766 | Q7Z408 | |
| HCGATPQWPEGYWEV | 911 | Q6L9W6 | |
| PQDLGWNPYVASWID | 2321 | Q96DT5 | |
| WWPTPADVSEDYEAD | 56 | Q17RM4 | |
| FPDWTFPSAWVCTYD | 886 | Q7Z2K6 | |
| CIRNEWGTNQGPWPY | 506 | O14525 | |
| DMFTWDPYGPWEGCT | 846 | P59510 | |
| PYFWPSNCWEPENTD | 116 | P49758 | |
| PYFWPTQQWPAEDTD | 106 | O75916 | |
| PFGSYSEEDIWWALE | 1386 | O15438 | |
| GWNNCYDYWIDADSP | 511 | Q96JM7 | |
| ESFCWPEWGLAEQYP | 141 | O60568 | |
| WKGPPDWTDYNDFEL | 1281 | P23467 | |
| WEFWVPSTPVGAYFC | 26 | Q8WZ33 | |
| VPRCFFPWNWGYEAS | 81 | Q2M2H8 | |
| CEWPLFWTYFILDGV | 326 | P46020 | |
| WPSYQLQDGEAWPPE | 326 | Q68D85 | |
| AGPWGDYLCDSPWAL | 56 | Q92485 | |
| TVFPDYTNPNCAVWW | 496 | O43451 | |
| ADYWYDILQSCWRPP | 381 | Q96Q04 | |
| GEWECPDTYWNSTNF | 231 | P04066 | |
| LPDIYGWPVATENWE | 161 | P08473 | |
| GQLDWYSWVPNAPCT | 546 | P16050 | |
| PEFTSIPACYWWAVI | 406 | Q9UIX4 | |
| CAWTKWFDVDFPSPG | 4631 | P98088 | |
| WCYTGNPLIPWDYCP | 451 | P14210 | |
| GQLDWYAWVPNAPCT | 546 | P18054 | |
| WLNYPCFKNWDGSPV | 326 | P00973 | |
| DCWAVFIQPWGPKAY | 186 | P30559 | |
| GPECDWWALGVFAYE | 256 | Q09013 | |
| SPPSLQDAEWYWGDI | 321 | O00459 | |
| IQEEFDRFTGYWWCP | 246 | Q86TI2 | |
| LPNYEATCWLWGDPH | 1666 | Q9Y6R7 | |
| CLPNYEATCWLWGDP | 2866 | Q9Y6R7 | |
| NGEDAVPYSWPWQVS | 31 | P08861 | |
| PGYTAFWQIWCALFP | 186 | Q8N6U8 | |
| PGPPWAAFATDEYQW | 336 | Q96PD2 | |
| WVIDFYAPWCGPCQN | 691 | Q8IXB1 | |
| EFCPTPDNWFSIEPW | 521 | Q6SJ93 | |
| GELWDTCNIGVPWYD | 131 | P13807 | |
| YWPCPPSLAVVETEW | 191 | Q08495 | |
| DEAWLVACAWPPFPY | 1396 | P98161 | |
| RYALWFCVGESWPQD | 341 | Q14653 | |
| QTPYFWPSNCWEPEN | 111 | P49802 | |
| WPSNCWEPENTDYAV | 116 | P49802 | |
| WCWDLESKFPEYGEF | 541 | Q7Z5M5 | |
| FGQYDWCSWIPNAPP | 556 | P09917 | |
| PDWPQSYSPGQDCVW | 541 | Q6UXD5 | |
| PLPDWFWSACPQAQY | 2076 | Q9UHV7 | |
| WCGTTTQGYLVWFEP | 571 | Q96JS3 | |
| DWLEEGIHWQYSPPD | 141 | Q5SWA1 | |
| PDIFWGCFLENETLW | 466 | Q7RTU9 | |
| YDSSPAAWNKEDFPW | 61 | P46063 | |
| NEPPWCFWDVPLIYS | 291 | Q9NUD9 | |
| GFFYPWSCEGDIWDR | 26 | Q8WZ59 | |
| RWKCPPEEEIYGNWS | 126 | Q9UHI7 | |
| RYTQPPTDLWDWFES | 166 | Q5VTL8 | |
| YCDVVGSPTPEIQWW | 51 | Q9Y639 | |
| EACWRFYPKFWTSPP | 1906 | Q9NY15 | |
| CFILPTLVPWYFWGE | 226 | O00767 | |
| PDIFWGCFLENETLW | 466 | A6NGW2 | |
| WCWDLEAGFPSYAEF | 616 | Q8TDI7 | |
| CNIFPCPAFWDIGEW | 671 | Q6ZMP0 | |
| CPSYWWNGDKYLGPA | 196 | P21912 | |
| FNWAFEECPPPSFSW | 166 | Q96LC7 | |
| PEGYETQWWDAPSIV | 311 | Q96SA4 | |
| FVPPTEYWNGWACFI | 791 | P32418 | |
| VGDDWCIMNWEPPAY | 631 | Q00872 |